We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register for real-time alerts, custom portfolio, and market movers
The current AURA market cap is 271.65M. The company's latest EPS is USD -1.9971 and P/E is -3.56.
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | |||
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -16.06M | -17.61M | -19.44M | -20.32M | -20.49M |
| Net Income | -15.9M | -16.56M | -17.47M | -18.3M | -18.51M |
| Year End 31 December 2023 | 2021 | 2022 | 2023 |
|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 |
| Operating Income | -35.25M | -60.3M | -84.99M |
| Net Income | -35.25M | -58.76M | -76.41M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | |||
| Total Assets | 143.15M | 223.94M | 206.02M | 192.74M | 179.77M |
| Total Liabilities | 28.09M | 28.35M | 25.76M | 26.3M | 28.05M |
| Total Equity | 115.05M | 195.58M | 180.26M | 166.44M | 151.72M |
| Year End 31 December 2023 | 2021 | 2022 | 2023 |
|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 160.03M | 223.94M | 255.08M |
| Total Liabilities | 7.72M | 28.35M | 29.23M |
| Total Equity | 152.32M | 195.58M | 225.85M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | |||
| Operating | -36.59M | -54.6M | -16.41M | -31.06M | -46.46M |
| Investing | -50.99M | -67.87M | -66.88M | -45.47M | -23.84M |
| Financing | 430k | 95.63M | 201k | 2.68M | 4.31M |
| Year End 31 December 2023 | 2021 | 2022 | 2023 |
|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | |
| Operating | -32.41M | -54.6M | -63.85M |
| Investing | -2.13M | -67.87M | -113.96M |
| Financing | 166.26M | 95.63M | 97.29M |
| Market Cap | 271.65M |
| Price to Earnings Ratio | -3.56 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 6.62 |
| Price to Book Ratio | 1.2 |
| Dividend Yield | - |
| Shares Outstanding | 38.26M |
| Average Volume (1 week) | 122.47k |
| Average Volume (1 Month) | 128.77k |
| 52 Week Change | -20.67% |
| 52 Week High | 13.50 |
| 52 Week Low | 5.99 |
| Spread (Intraday) | 2.38 (25.37%) |
| Company Name | Aura Biosciences Inc |
| Address |
corporation trust center wilmington, delaware 19801 |
| Website | https://www.aurabiosciences.com |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
